Stero Therapeutics
PrivateLast Round
Early Funding
Feb 27, 2018
Company Overview
Stero Therapeutics is a pharmaceutical company that develops novel therapies for rare metabolic diseases, with an initial focus on Cushing's syndrome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stero Therapeutics Comparables
Compare Stero Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sparrow Pharmaceuticals | 82% | |
| MBX Biosciences | 75% | |
| AstraZeneca | 72% |
Stero Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 27, 2018 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 27, 2018
Completed an early funding round.
Stero Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Stero Therapeutics's valuation, stock price, and market status.
Is Stero Therapeutics a public or private company?
Stero Therapeutics is a private company.
What is the current stock price of Stero Therapeutics?
Stero Therapeutics is a private company with no public stock price. Caplight tracks Stero Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Stero Therapeutics worth (valuation)?
Valuation information for Stero Therapeutics is not publicly available.
Can I buy Stero Therapeutics stock?
Stero Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Stero Therapeutics's last funding round?
Stero Therapeutics's most recent funding round was Early Funding on February 27, 2018.
Who are the main investors in Stero Therapeutics?
Investor information for Stero Therapeutics is not publicly disclosed.
Will Stero Therapeutics IPO soon?
No public IPO plans have been announced for Stero Therapeutics.
How can I track Stero Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stero Therapeutics's secondary market activity and sign up for updates.